Trials / Completed
CompletedNCT06559839
Vestibular Innovation in Pain
Vestibular Innovation in Pain: An Open Label Trial
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 39 (actual)
- Sponsor
- Icahn School of Medicine at Mount Sinai · Academic / Other
- Sex
- All
- Age
- 18 Years – 99 Years
- Healthy volunteers
- Not accepted
Summary
The VIP trial will assess the effectiveness, tolerability, and durability of effect of vestibulocortical stimulation (VCS) - a safe \& cost-effective bedside technique - in treating pain, fatigue \& related symptoms using validated patient-reported outcomes. Data from this trial will be used to guide optimized treatment protocols in future randomized controlled trials and help inform the implementation of VCS into standard clinical practice.
Detailed description
VCS is a form of non-invasive neuromodulation whereby cold water is irrigated into the external ear canal.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Vestibulocortical Stimulation | 50cc of cold water (4℃) irrigated to the right external ear canal, at 1-2 cc/second, with the patient laying supine. |
Timeline
- Start date
- 2024-10-01
- Primary completion
- 2025-03-06
- Completion
- 2025-03-06
- First posted
- 2024-08-19
- Last updated
- 2025-07-03
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT06559839. Inclusion in this directory is not an endorsement.